Wednesday, September 02

Top Stories

December 01, 2025

Buy, Sell or Hold: Citi maintains buy on largecap pharma stocks like Lupin & Sun Pharma

Brokerage sentiment across the pharmaceutical and emerging workspace sectors remains broadly optimistic, with firms such as Citi and Choice Institutional Equities highlighting robust growth drivers and improving earnings visibility for key players.Citi continues to back large-cap pharma names like Lupin and Sun Pharma, citing strong momentum in their US businesses, healthy product pipelines, and structural margin levers that are expected to support sustained profitability over the next few years.Meanwhile, Choice Institutional Equities has initiated coverage on Smartworks with a bullish outlook, underscoring the rapid expansion of India’s flexible workspace market and the company’s strong positioning within this high-growth segment.Collectively, these recommendations signal confidence

December 01, 2025

Ministry of Tourism signs pact with Netflix

The Ministry of Tourism has entered into a "non-commercial" MoU with Netflix Entertainment Services India to promote the country's tourism destinations globally through cinematic storytelling, the government informed Parliament on Monday. The Memorandum of Understanding (MoU) with the OTT platform includes promotion of natural landscape, cultural and heritage sites of the country, including the state of Gujarat, Union Tourism Minister Gajendra Singh Shekhawat said in a written response to a query in the Lok Sabha. He was asked whether the government has entered into a partnership with Netflix to promote tourism in India through visual storytelling and on-screen representation of destinations. "The Ministry of Tourism entered into a non-commercial Memorandum of Understanding (MoU) with Netf

770